Brief: Avenue Therapeutics Announces Reverse Stock Split
24/04/2024 12:53
April 24 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT
* AVENUE THERAPEUTICS INC: ANNOUNCED THAT IT WILL EFFECT A
1-FOR-75 REVERSE SPLIT OF ITS ISSUED AND OUTSTANDING COMMON
STOCK
* AVENUE THERAPEUTICS : REVERSE STOCK SPLIT IS INTENDED TO
BRING
THE CO INTO COMPLIANCE WITH NASDAQ’S $1.00 PER SHARE MINIMUM BID
PRICE REQUIREMENT
Source text for Eikon: ID:nGNX1VQ5RJ
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi